Effectiveness of a specific care plan in patients with Alzheimer's disease: Cluster randomised trial (PLASA study)

BMJ (Online)

Volumn 340, Issue 7760, 2010, Pages 1346-

  Nourhashemi, Fati ^a,b,c   Andrieu, Sandrine ^a,b,c,d   Gillette Guyonnet, Sophie ^a,b,c   Giraudeau, Bruno ^b,e,f   Cantet, Christelle ^b,c   Coley, Nicola ^b,c   Vellas, Bruno ^a,b,c  

^a CMRR ^*  (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE TOURS   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FEMALE; FRANCE; FUNCTIONAL STATUS; HEALTH CARE PLANNING; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMBULATORY CARE; CAREGIVERS; CLUSTER ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PATIENT CARE PLANNING; TREATMENT OUTCOME;

EID: 77953709460     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c2466     Document Type: Article

References (34)

1. Lyketsos CG, Colenda CC, Beck C, Blank K, Doraiswamy MP, Kalunian DA, et al. Task Force of the American Association for Geriatric Psychiatry. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006;14:561-72.
2. Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-71.
3. Grossberg GT, Desai AK. Management of Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2003;58:331-53.
4. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14:e1-26.
5. Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, et al. Improving adherence to dementia guidelines through education and opinion leaders: a randomized, controlled trial. Ann InternMed 1999;131:237-46.
6. Chodosh J, Mittman BS, Connor KI, Vassar SD, Lee ML, DeMonte RW, et al. Caring for patients with dementia: how good is the quality of care? Results from three health systems. J Am Geriatr Soc 2007;55:1260-8.
7. Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA 2006;295:2148-57.
8. Vickrey BG, Mittman BS, Connor KI, Pearson ML, Della Penna RD, Ganiats TG, et al. The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Intern Med 2006;145:713-26.
9. Chenoweth L, King MT, Jeon YH, Brodaty H, Stein-Parbury J, Norman R, et al. Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol 2009;8:317-25.
10. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
11. Campbell MK, Elbourne DR, Altman DG, for the CONSORT group. The CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702-8.
12. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSO RT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44. (Pubitemid 14076461)
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
15. Gillette-Guyonnet S, Nourhashémi F, Andrieu S, Cantet C, Micas M, Ousset PJ, et al. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 2003;7:91-6.
16. Fillit H, Cummings J. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II - pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Manag Care Interface 2000;13:51-6.
17. Harvey RJ. A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease. Int J Geriatr Psychiatry 1999;14:249-56.
18. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1154-66.
19. Perera R, Heneghan C, Yudkin P. Graphical method for depicting randomised trials of complex interventions. BMJ 2007;334:127-9. (Pubitemid 46173954)
20. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-9.
21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-86.
22. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutr Rev 1996;54:59-65S.
23. Cummings JL, Mega M, Gray R, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14. (Pubitemid 24382728)
24. Vellas B, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 1997;45:735-8. (Pubitemid 27248784)
25. Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 1986;26:260-6.
26. Galasko D, Benett D, Sano M, Ernesto C, Thomas R, Grundman M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11(suppl 2):33-9S.
27. Fillenbaum GG, Peterson B, Welsh-Bohmer KA, Kukull WA, Heyman A. Progression of Alzheimer's disease in black and white patients: the CERAD experience, part XVI. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998;51:154-8.
28. Koss E, Peterson B, Fillenbaum GG. Determinants of attrition in a natural history study of Alzheimer disease. Alzheimer Dis Assoc Disord 1999;13:209-15. (Pubitemid 30011378)
29. Schneider LS, Sano M. Current Alzheimer's disease clinical trials: methods and placebo outcomes. Alzheimers Dement 2009;5:388-97.
30. WilcockGK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurol 2008;7:483-93.
31. Sevigny JJ, Ryan JM, vanDyck CH, Peng Y, Lines CR, Nessly ML; MK- 677 Protocol 30 Study Group. Growth hormone secretagogue MK- 677. No clinical effect on AD progression in a randomized trial. Neurology 2008;71:1702-8.
32. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967;20:637-48.
33. Molnar FJ, Hutton B, Fergusson D. Does analysis using "last observation carried forward" introduce bias in dementia research? CMAJ 2008;179:751-3.
34. Boutron I, Tubach F, Giraudeau B, Ravaud P. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol 2004;57:543-50.